Xtant Medical Holdings (FRA:XMS) Additional Paid-In Capital : €271.61 Mil(As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Xtant Medical Holdings Additional Paid-In Capital?

Xtant Medical Holdings's quarterly additional paid-in capital declined from Sep. 2023 (€275.04 Mil) to Dec. 2023 (€269.90 Mil) but then increased from Dec. 2023 (€269.90 Mil) to Mar. 2024 (€271.61 Mil).

Xtant Medical Holdings's annual additional paid-in capital increased from Dec. 2021 (€235.47 Mil) to Dec. 2022 (€262.28 Mil) and increased from Dec. 2022 (€262.28 Mil) to Dec. 2023 (€269.90 Mil).

Xtant Medical Holdings Additional Paid-In Capital Historical Data

The historical data trend for Xtant Medical Holdings's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Xtant Medical Holdings Additional Paid-In Capital Chart

Xtant Medical Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Additional Paid-In Capital

Get a 7-Day Free Trial

161.16

201.27

235.47

262.28

269.90

Xtant Medical Holdings Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Additional Paid-In Capital	Get a 7-Day Free Trial															260.08	257.42	275.04	269.90	271.61

Xtant Medical Holdings Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Xtant Medical Holdings Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Xtant Medical Holdings's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Xtant Medical Holdings (FRA:XMS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Xtant Medical Holdings Inc (FRA:XMS) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

XTNT:USA

Address

664 Cruiser Lane, Belgrade, MT, USA, 59714

Website

http://www.xtantmedical.com

Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect DBM putty, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the US.

Xtant Medical Holdings (FRA:XMS) Headlines

No Headlines